Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

Daniel Jeffrey Moore net worth and biography

Daniel Moore Biography and Net Worth

Director of LivaNova

Daniel Moore has primarily worked as a private investor over the past five years. Mr. Moore served as President and CEO and a member of the board of Cyberonics, Inc., a medical device company with core expertise in neuromodulation, from 2007 to 2015 when Cyberonics merged with Sorin S.p.A. to form the Company. Mr. Moore joined Cyberonics after 18 years with Boston Scientific where he was President of InterContinental as well as having roles in general management, sales and marketing earlier in his career. Mr. Moore has a B.A. from Harvard College and an Executive M.B.A. from Boston University.

Mr. Moore has extensive experience working with cutting edge medical device companies, including leadership of Cyberonics. He has significant experience in domestic and international general management and sales and marketing. Mr. Moore serves or has served on the boards of several medical device companies, the Epilepsy Foundation of America and other non-profits focused on epilepsy, the Medical Device Manufacturers Association and the Advisory Board of Purdue University’s Weldon School of Biomedical Engineering.

What is Daniel Jeffrey Moore's net worth?: The estimated net worth of Daniel Jeffrey Moore is at least $1.38 million as of June 3rd, 2024. Mr. Moore owns 27,534 shares of LivaNova stock worth more than $1,378,077 as of November 20th. This net worth approximation does not reflect any other investments that Mr. Moore may own. Learn More about Daniel Jeffrey Moore's net worth.
How do I contact Daniel Jeffrey Moore?: The corporate mailing address for Mr. Moore and other LivaNova executives is 20 EASTBOURNE TERRACE, LONDON X0, W2 6LG. LivaNova can also be reached via phone at 442033250660 and via email at [email protected]. Learn More on Daniel Jeffrey Moore's contact information.
Has Daniel Jeffrey Moore been buying or selling shares of LivaNova?: Daniel Jeffrey Moore has not been actively trading shares of LivaNova within the last three months. Most recently, Daniel Jeffrey Moore sold 56,623 shares of the business's stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $60.11, for a transaction totalling $3,403,608.53. Following the completion of the sale, the director now directly owns 27,534 shares of the company's stock, valued at $1,655,068.74. Learn More on Daniel Jeffrey Moore's trading history.
Who are LivaNova's active insiders?: LivaNova's insider roster includes Marco Dolci (SVP), Damien McDonald (CEO), Daniel Moore (Director), and Alfred Novak (Director). Learn More on LivaNova's active insiders.
Are insiders buying or selling shares of LivaNova?: During the last year, insiders at the sold shares 1 times. They sold a total of 56,623 shares worth more than $3,403,608.53. The most recent insider tranaction occured on June, 3rd when Director Daniel Jeffrey Moore sold 56,623 shares worth more than $3,403,608.53. Insiders at LivaNova own 0.3% of the company. Learn More about insider trades at LivaNova.
Information on this page was last updated on 6/3/2024.

Daniel Jeffrey Moore Insider Trading History at LivaNova

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/3/2024	Sell	56,623	$60.11	$3,403,608.53	27,534
4/1/2022	Sell	1,000	$83.42	$83,420.00	24,630
3/2/2022	Sell	1,000	$80.00	$80,000.00
2/25/2022	Sell	1,000	$80.00	$80,000.00
1/3/2022	Sell	1,000	$85.93	$85,930.00
12/1/2021	Sell	1,000	$81.73	$81,730.00
11/3/2021	Sell	1,000	$85.25	$85,250.00
10/1/2021	Sell	1,000	$80.00	$80,000.00
9/1/2021	Sell	1,000	$82.40	$82,400.00	31,630
8/2/2021	Sell	1,000	$86.39	$86,390.00	32,630
11/22/2019	Sell	3,000	$80.00	$240,000.00	28,352
9/16/2019	Sell	1,500	$84.56	$126,840.00
8/19/2019	Sell	1,500	$80.25	$120,375.00
8/1/2019	Sell	6,000	$80.00	$480,000.00	34,352
3/15/2019	Sell	1,500	$96.63	$144,945.00
2/15/2019	Sell	1,500	$100.44	$150,660.00
1/15/2019	Sell	1,500	$90.80	$136,200.00
12/15/2018	Sell	1,000	$91.85	$91,850.00
11/15/2018	Sell	1,000	$116.68	$116,680.00
10/15/2018	Sell	1,000	$113.30	$113,300.00
9/17/2018	Sell	1,000	$123.49	$123,490.00
8/15/2018	Sell	1,000	$121.58	$121,580.00
7/16/2018	Sell	1,000	$102.19	$102,190.00
5/15/2018	Sell	1,000	$84.66	$84,660.00
4/16/2018	Sell	1,000	$86.24	$86,240.00
3/15/2018	Sell	1,000	$88.31	$88,310.00
2/15/2018	Sell	1,000	$83.32	$83,320.00
1/16/2018	Sell	1,000	$82.15	$82,150.00
12/15/2017	Sell	1,000	$80.80	$80,800.00
11/15/2017	Sell	1,000	$81.39	$81,390.00
10/16/2017	Sell	1,000	$74.58	$74,580.00
9/15/2017	Sell	1,000	$68.55	$68,550.00	57,296
8/15/2017	Sell	1,000	$60.76	$60,760.00	58,296
7/17/2017	Sell	1,000	$61.55	$61,550.00	56,437
6/15/2017	Sell	1,000	$60.80	$60,800.00	57,437
4/17/2017	Sell	1,000	$51.32	$51,320.00	59,437
3/15/2017	Sell	1,000	$50.21	$50,210.00	60,437
5/24/2016	Sell	1,000	$50.07	$50,070.00	64,137
4/15/2016	Sell	1,000	$54.81	$54,810.00	64,437
3/15/2016	Sell	1,000	$56.88	$56,880.00	65,437
2/16/2016	Sell	1,000	$56.88	$56,880.00	66,437
1/15/2016	Sell	1,000	$52.64	$52,640.00	67,437
12/15/2015	Sell	2,500	$53.97	$134,925.00	68,437

Daniel Jeffrey Moore Buying and Selling Activity at LivaNova

LivaNova Company Overview

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Today's Range

Now: $50.05

$49.98

$51.75

50 Day Range

MA: $51.96

$47.45

$53.83

2 Week Range

Now: $50.05

$42.75

$64.47

Volume

395,983 shs

Average Volume

615,608 shs

Market Capitalization

$2.72 billion

P/E Ratio

119.17

Dividend Yield

N/A

Beta

1.01

JD Vance Predicts: Wall Street vs. Trump & Your Money

From Priority Gold | Ad

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.